WEDINOS is a harm reduction project, and reflects trends in substance use. It is therefore important that samples are submitted with a completed 'Effects Record' and correct postcode information, including samples from outside of Wales. This does not affect your anonymity.
Any samples with web generated reference numbers (WXXXXXX) that do not have a completed 'Effects Record' or conflicting information re: correct postcode will not have their results published.
The sample profile generated as a result of analysis relates to only that sample and cannot be used to indicate the contents, profile or quality of a wider batch of the substance.
Health professionals: please refer to TOXBASE for current management advice
Following a review by the WEDINOS Programme Board, it has been decided that as of 25th July 2014, no further samples of Steroids and/or Image Enhancing drugs (SIEDs) will be tested by WEDINOS. For further information please click here.
Search
4650 results were found
4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 « Previous Next » 8 of 233Sample W006266
The sample was not analysed for the following reason : Postcode - postmark conflict
Sample W006263
Date Received: 15/03/2017
Postcode: NR4
Purchase Intent: Psychedelic Rush
Package Label: Not Stated
Sample Colour: Purple
Sample Form: Tablet
Consumption Method: Not Stated
Self-Reported Effects: Harm Reduction
Sample Upon Analysis (Major): 2C-B
Sample Upon Analysis (Minor):
Sample W006268
Date Received: 15/03/2017
Postcode: NR4
Purchase Intent: Psychedelic Rush
Package Label: Not Stated
Sample Colour: Purple
Sample Form: Tablet
Consumption Method: Not Stated
Self-Reported Effects: Not Stated
Sample Upon Analysis (Major): 2C-B
Sample Upon Analysis (Minor):
Sample W006264
Date Received: 15/03/2017
Postcode: CH6
Purchase Intent: Cannabis
Package Label: Not Stated
Sample Colour: Green, Brown
Sample Form: Plant Matter
Consumption Method: Not Stated
Self-Reported Effects: Not Stated
Sample Upon Analysis (Major): Nicotine
Sample Upon Analysis (Minor):
Sample W006262
The sample was not analysed for the following reason : Inappropriate submission
Sample W006260
Date Received: 14/03/2017
Postcode: SE1
Purchase Intent: MDMA
Package Label: psychedelic MDMA
Sample Colour:
Sample Form:
Consumption Method: Not Stated
Self-Reported Effects: Not Stated
Sample Upon Analysis (Major): MDMA
Sample Upon Analysis (Minor):
Sample W006258
The sample was not analysed for the following reason : Inappropriate submission
Sample W006261
Date Received: 14/03/2017
Postcode: EC1
Purchase Intent: Mephedrone
Package Label: Not Stated
Sample Colour: Brown
Sample Form: Crystalline
Consumption Method: Snort / Sniff
Self-Reported Effects: Euphoria, Nosebleeds, Nausea
Sample Upon Analysis (Major): Mexedrone
Sample Upon Analysis (Minor): Caffeine
Sample W006247
Date Received: 14/03/2017
Postcode: KT6
Purchase Intent: Diazepam
Package Label: WW D/10
Sample Colour: Blue
Sample Form: Tablet
Consumption Method: Oral
Self-Reported Effects: Euphoria, Increased Confidence, Empathy, Relaxed
Sample Upon Analysis (Major): Diclazepam
Sample Upon Analysis (Minor):
Sample W006253
The sample was not analysed for the following reason : Inappropriate submission
Sample W006252
Date Received: 14/03/2017
Postcode: LS7
Purchase Intent: Fentanyl-HCL + Mannitol 15% fentanyl
Package Label: Not Stated
Sample Colour: White
Sample Form: Powder
Consumption Method: Intravenous
Self-Reported Effects: Euphoria, Increased Confidence, Relaxed, Nausea, Harm Reduction
Sample Upon Analysis (Major): Carfentanyl, Mannitol
Sample Upon Analysis (Minor):
Sample W006254
Date Received: 14/03/2017
Postcode: LS7
Purchase Intent: Fentanyl HCL
Package Label: Not Stated
Sample Colour: White
Sample Form: Powder
Consumption Method: Intravenous
Self-Reported Effects: Euphoria, Relaxed
Sample Upon Analysis (Major): Fentanyl
Sample Upon Analysis (Minor):
Sample W006255
Date Received: 14/03/2017
Postcode: LS57
Purchase Intent: Fentanyl HCL
Package Label: Not Stated
Sample Colour: White
Sample Form: Powder
Consumption Method: Not Stated
Self-Reported Effects: Harm Reduction
Sample Upon Analysis (Major): furanylfentanyl
Sample Upon Analysis (Minor):
Sample W006256
Date Received: 14/03/2017
Postcode: LS7
Purchase Intent: Alprazolam powder
Package Label: Not Stated
Sample Colour: Yellow, Orange
Sample Form: Powder
Consumption Method: Oral
Self-Reported Effects: Increased Confidence, Relaxed
Sample Upon Analysis (Major): Alprazolam
Sample Upon Analysis (Minor):
Sample W006259
Date Received: 14/03/2017
Postcode: SE1
Purchase Intent: MDMA
Package Label: MDMA extra
Sample Colour: Brown
Sample Form: Granules
Consumption Method: Not Stated
Self-Reported Effects: Harm Reduction
Sample Upon Analysis (Major): MDMA
Sample Upon Analysis (Minor):
Sample 000036863
Date Received: 10/03/2017
Postcode: LL65
Purchase Intent: Excel Pharma - Tronoject A100 - Trenbolone Acetate
Package Label: Not Stated
Sample Colour: Yellow
Sample Form: Liquid
Consumption Method: Not Stated
Self-Reported Effects: Not Stated
Sample Upon Analysis (Major): Testosterone propionate
Sample Upon Analysis (Minor):
Sample 000036862
Date Received: 10/03/2017
Postcode: LL65
Purchase Intent: Rextec Pharmaceutical Testosterone Propionate
Package Label: Not Stated
Sample Colour: Yellow
Sample Form: Liquid
Consumption Method: Not Stated
Self-Reported Effects: Not Stated
Sample Upon Analysis (Major): Testosterone propionate, Testosterone cypionate
Sample Upon Analysis (Minor):
Sample W006245
Date Received: 09/03/2017
Postcode: TW20
Purchase Intent: Focus
Package Label: Modafinil
Sample Colour: White
Sample Form: Tablet
Consumption Method: Oral
Self-Reported Effects: Euphoria, Increased Energy, Empathy, Irregular Heartbeat, Insomnia
Sample Upon Analysis (Major): Modafinil
Sample Upon Analysis (Minor):
Sample 000041707
Date Received: 09/03/2017
Postcode: SY23
Purchase Intent: MSJ
Package Label: Not Stated
Sample Colour: Blue
Sample Form: Tablet
Consumption Method: Oral
Self-Reported Effects: Relaxed
Sample Upon Analysis (Major): Diazepam
Sample Upon Analysis (Minor):
Sample 000035323
Date Received: 08/03/2017
Postcode: CF47
Purchase Intent: Hospital
Package Label: Not Stated
Sample Colour: Orange
Sample Form: Tablet
Consumption Method: Not Stated
Self-Reported Effects: Not Stated
Sample Upon Analysis (Major): Buprenorphine, Mannitol
Sample Upon Analysis (Minor):
Identified in Sweden: 7-chloro-5-(2-fluorophenyl)-1,3-dihydro-1,4-benzodiazepin-2-one (norfludiazepam). Norfludiazepam is a benzodiazepine and is structurally related to the internationally controlled substance diazepam.
Essential Maintenance: The WEDINOS primary analytical tools are currently undergoing essential maintenance. This will result in a delay in analysis and publication of results. Thank you for your patience.